That’s a concise and spot-on summary, as well as a warning for prospective Cassava investors. SAVA stock was down several percentage points, even though there wasn’t any company specific news ...

On the morning of Jan. 20, 2022, Texas-based clinical-stage biotechnology company Cassava Sciences (NASDAQ:SAVA) was trending on financial message board StockTwits as traders were buzzing about ...